RPI
ALNY icon

Railway Pension Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Railway Pension Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,000
Closed -$4.15M – 269
2020
Q2 		$4.15M Sell
28,000
-600
-2% -$80.9K 0.05% 248
2020
Q1 		$3.11M Buy
28,600
+500
+2% +$57.7K 0.04% 277
2019
Q4 		$3.24M Buy
+28,100
New +$2.8M 0.04% 300

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Railway Pension Investments's ALNY Position: Q3 2020 in Review

Railway Pension Investments sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2020, closing a stake of 28,000 shares — an estimated $4.15M sold.

Railway Pension Investments first reported a position in ALNY in Q4 2019 and held it in 3 quarters. The position peaked at $4.15M in Q2 2020. 357 funds tracked by Wall St. Rank hold ALNY as of Q3 2020.

  • Railway Pension Investments reported no remaining Alnylam Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Railway Pension Investments sold 28,000 Alnylam Pharmaceuticals shares in Q3 2020, an estimated $4.15M.
  • Railway Pension Investments first reported a position in Alnylam Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Railway Pension Investments's Alnylam Pharmaceuticals position peaked at $4.15M in Q2 2020.
  • 357 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2020.

Based on Railway Pension Investments's 13F filing for Q3 2020, filed 29 Oct 2020.